Overview

CLL Empirical Antibiotic Regimen

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether patients with previously untreated, early stage CLL respond to empirical broad spectrum antibiotics and therefore test the hypothesis that occult bacterial infections are involved in the induction and maintenance of CLL.
Phase:
Phase 2
Details
Lead Sponsor:
King's College Hospital NHS Trust
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Ciprofloxacin
Clarithromycin
Dexlansoprazole
Lansoprazole
Metronidazole